Literature DB >> 3681296

Large alterations in ganglioside and neutral glycosphingolipid patterns in brains from cases with infantile neuronal ceroid lipofuscinosis/polyunsaturated fatty acid lipidosis.

L Svennerholm1, P Fredman, B Jungbjer, J E Månsson, B M Rynmark, K Boström, B Hagberg, L Norén, P Santavuori.   

Abstract

Lipid composition was studied on cerebral tissue from nine children who had died of a progressive encephalopathy called the infantile form of neuronal ceroid lipofuscinosis (INCL) or polyunsaturated fatty acid lipidosis (PFAL). In the terminal stage of the disease, the concentrations of all lipid classes were found to be significantly reduced in the cerebral and cerebellar cortex and white matter. The concentration of gangliosides of the cerebral cortex was 15% and that of cerebrosides (galactosylceramide) in white matter 0.2-5% of the normal values for the children's ages. The reduction of gangliosides mainly affected those of the gangliotetraose series, particularly GD1a. The fatty acids of the linolenic acid series were strongly reduced in ethanolamine and serine phosphoglycerides. A very large increase up to 100-fold of oligoglycosphingolipids of the globo series and two fucose-containing lipids of the neolacto series was found in the forebrain of the three advanced cases examined. The brain tissue also contained very high concentrations of mono-, di-, and trisialogangliosides of the lacto and neolacto series, gangliosides with type 1 chain dominating. The structures of the gangliosides were tentatively identified by gas chromatography-mass spectrometry and monoclonal antibodies with carefully determined epitope specificity. The gangliosides and neutral glycosphingolipids had very similar fatty acid composition, consisting of about 40% stearic acid and 40% C24-acids.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3681296     DOI: 10.1111/j.1471-4159.1987.tb02435.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

1.  Characterization of SSEA-1 glycolipids from the brain of a patient with fucosidosis.

Authors:  G A Schwarting; M A Williams; J E Evans; R H McCluer
Journal:  Glycoconj J       Date:  1989       Impact factor: 2.916

2.  Late-infantile Gaucher disease in a child with myoclonus and bulbar signs: neuropathological and neurochemical findings.

Authors:  N Conradi; M Kyllerman; J E Månsson; A K Percy; L Svennerholm
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

3.  Ganglioside mapping of a human medulloblastoma xenograft.

Authors:  J Gottfries; J E Mansson; P Fredman; C J Wikstrand; H S Friedman; D D Bigner; L Svennerholm
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

4.  Affinity-matured recombinant immunotoxin targeting gangliosides 3'-isoLM1 and 3',6'-isoLD1 on malignant gliomas.

Authors:  Hailan Piao; Chien-Tsun Kuan; Vidya Chandramohan; Stephen T Keir; Charles N Pegram; Xuhui Bao; Jan-Eric Månsson; Ira H Pastan; Darell D Bigner
Journal:  MAbs       Date:  2013-07-25       Impact factor: 5.857

Review 5.  Secondary lipid accumulation in lysosomal disease.

Authors:  Steven U Walkley; Marie T Vanier
Journal:  Biochim Biophys Acta       Date:  2008-12-09

6.  Didemnin binds to the protein palmitoyl thioesterase responsible for infantile neuronal ceroid lipofuscinosis.

Authors:  C M Crews; W S Lane; S L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

7.  Modest phenotypic improvements in ASA-deficient mice with only one UDP-galactose:ceramide-galactosyltransferase gene.

Authors:  S Franken; D Wittke; J E Mansson; R D'Hooge; P P De Deyn; R Lüllmann-Rauch; U Matzner; V Gieselmann
Journal:  Lipids Health Dis       Date:  2006-08-07       Impact factor: 3.876

8.  GBA2 Mutations Cause a Marinesco-Sjögren-Like Syndrome: Genetic and Biochemical Studies.

Authors:  Kristoffer Haugarvoll; Stefan Johansson; Carlos E Rodriguez; Helge Boman; Bjørn Ivar Haukanes; Ove Bruland; Francisco Roque; Inge Jonassen; Maria Blomqvist; Wenche Telstad; Jan-Eric Månsson; Per Morten Knappskog; Laurence A Bindoff
Journal:  PLoS One       Date:  2017-01-04       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.